Bowe, Kaitlin

Bowe, Kaitlin was paid $141K by Medicaid between Jan 2018 and Jul 2024, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 43% of everything it billed.

33Billing provider infoBOWE, KAITLIN
MIDDLETOWN, NY 10941

33aNPI1740547637assigned 04/16/2012

33bProvider typeFamily Nurse Practitioner

28Total paid$141K

24GClaims1,466

24DCodes billed7

24AFirst – last monthJan 2018 – Jul 2024

Compared with peers

Next to other Family Nurse Practitioner providers in New York

Rank by total paid#77 of 1,582

Median peer was paid$2K

This provider vs. median62×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	35	$3K
2019	202	$18K
2020	296	$24K
2021	217	$24K
2022	553	$62K
2023	151	$11K
2024incomplete	12	$207.06

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	43%	757	741	$61K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	26%	264	262	$36K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	23%	315	314	$32K
S9083	Global fee urgent care centers	4.1%	39	39	$6K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	3.8%	60	59	$5K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	14	14	$459.68
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	17	17	$413.75

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.